NASDAQ:SPRO

Spero Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy SPRO

*Your capital is at risk

$2.80

-0.0300 (-1.06%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

SPRO Prediction Chart

SPRO Predictions History

Latest community submissions for SPRO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
AlexVel Pro	Sep 13, 2022	$1.07 -0.65%	$1.04	V	96.83%	1
JS Pro	Sep 13, 2022	$1.06 -1.85%	$1.04	V	98.08%	1
swensenelena.342783	Sep 13, 2022	Bullish	$1.04	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SPRO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SPERO THERAPEUTICS INC.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct actin...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by